Trial Profile
Post Marketing Surveillance of Remicade in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Ankylosing spondylitis; Psoriasis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Schering-Plough
- 20 Jun 2012 Actual patient numbers amended from 125 to 1055 as reported by ClinicalTrials.gov.
- 20 Jun 2012 Actual end date changed from May 2011 to Apr 2011 as reported by ClinicalTrials.gov.
- 20 Jun 2012 Official Title amended as reported by ClinicalTrials.gov.